Rick Wise
Stock Analyst at Stifel
(4.37)
# 355
Out of 4,960 analysts
243
Total ratings
63.45%
Success rate
11.76%
Average return
Main Sectors:
Stocks Rated by Rick Wise
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMCI Treace Medical Concepts | Maintains: Hold | $9 → $6 | $7.70 | -22.08% | 9 | Aug 8, 2025 | |
| AORT Artivion | Maintains: Buy | $36 → $40 | $44.83 | -10.77% | 7 | Aug 8, 2025 | |
| BAX Baxter International | Downgrades: Hold | $36 → $25 | $24.54 | +1.87% | 9 | Aug 4, 2025 | |
| LUNG Pulmonx | Maintains: Buy | $16 → $5 | $1.69 | +195.86% | 5 | Jul 31, 2025 | |
| EW Edwards Lifesciences | Maintains: Buy | $90 → $95 | $81.83 | +16.09% | 24 | Jul 25, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Buy | $138 → $115 | $107.71 | +6.77% | 15 | May 6, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $280 → $224 | $199.66 | +12.19% | 8 | May 2, 2025 | |
| CNMD CONMED | Downgrades: Hold | $75 → $55 | $55.81 | -1.45% | 12 | Apr 28, 2025 | |
| ABT Abbott Laboratories | Maintains: Buy | $135 → $145 | $132.59 | +9.36% | 20 | Apr 17, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Buy | $28 | $18.58 | +50.74% | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $32 | $20.20 | +58.42% | 6 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $60 | $55.90 | +7.33% | 6 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $48 | $37.66 | +27.46% | 13 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $120 | $106.17 | +13.03% | 17 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $440 | $394.22 | +11.61% | 16 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $170 → $155 | $179.29 | -13.55% | 6 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $525 → $610 | $476.16 | +28.11% | 17 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $170 → $190 | $148.63 | +27.83% | 14 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $82 | $73.55 | +11.49% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $102 | $75.22 | +35.60% | 2 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $85 → $87 | $92.71 | -6.16% | 11 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $9 → $12 | $4.74 | +153.16% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $59 → $75 | $100.33 | -25.25% | 1 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $17 → $24 | $11.93 | +101.17% | 7 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $390 → $90 | $14.20 | +533.80% | 4 | Oct 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $25 | $11.71 | +113.49% | 4 | Jun 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $103 → $112 | $48.63 | +130.31% | 5 | Oct 2, 2020 |
Treace Medical Concepts
Aug 8, 2025
Maintains: Hold
Price Target: $9 → $6
Current: $7.70
Upside: -22.08%
Artivion
Aug 8, 2025
Maintains: Buy
Price Target: $36 → $40
Current: $44.83
Upside: -10.77%
Baxter International
Aug 4, 2025
Downgrades: Hold
Price Target: $36 → $25
Current: $24.54
Upside: +1.87%
Pulmonx
Jul 31, 2025
Maintains: Buy
Price Target: $16 → $5
Current: $1.69
Upside: +195.86%
Edwards Lifesciences
Jul 25, 2025
Maintains: Buy
Price Target: $90 → $95
Current: $81.83
Upside: +16.09%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Buy
Price Target: $138 → $115
Current: $107.71
Upside: +6.77%
Becton, Dickinson and Company
May 2, 2025
Maintains: Buy
Price Target: $280 → $224
Current: $199.66
Upside: +12.19%
CONMED
Apr 28, 2025
Downgrades: Hold
Price Target: $75 → $55
Current: $55.81
Upside: -1.45%
Abbott Laboratories
Apr 17, 2025
Maintains: Buy
Price Target: $135 → $145
Current: $132.59
Upside: +9.36%
Kestra Medical Technologies
Mar 31, 2025
Initiates: Buy
Price Target: $28
Current: $18.58
Upside: +50.74%
Mar 5, 2025
Maintains: Buy
Price Target: $40 → $32
Current: $20.20
Upside: +58.42%
Feb 26, 2025
Maintains: Buy
Price Target: $72 → $60
Current: $55.90
Upside: +7.33%
Feb 13, 2025
Maintains: Buy
Price Target: $36 → $48
Current: $37.66
Upside: +27.46%
Feb 10, 2025
Maintains: Buy
Price Target: $115 → $120
Current: $106.17
Upside: +13.03%
Jan 29, 2025
Maintains: Buy
Price Target: $400 → $440
Current: $394.22
Upside: +11.61%
Jan 23, 2025
Maintains: Hold
Price Target: $170 → $155
Current: $179.29
Upside: -13.55%
Dec 5, 2024
Maintains: Buy
Price Target: $525 → $610
Current: $476.16
Upside: +28.11%
Nov 22, 2024
Reiterates: Buy
Price Target: $170 → $190
Current: $148.63
Upside: +27.83%
Oct 8, 2024
Initiates: Buy
Price Target: $82
Current: $73.55
Upside: +11.49%
Sep 30, 2024
Maintains: Buy
Price Target: $100 → $102
Current: $75.22
Upside: +35.60%
Aug 21, 2024
Maintains: Hold
Price Target: $85 → $87
Current: $92.71
Upside: -6.16%
Jul 16, 2024
Upgrades: Buy
Price Target: $9 → $12
Current: $4.74
Upside: +153.16%
Apr 26, 2024
Upgrades: Buy
Price Target: $59 → $75
Current: $100.33
Upside: -25.25%
Feb 5, 2024
Maintains: Hold
Price Target: $17 → $24
Current: $11.93
Upside: +101.17%
Oct 13, 2023
Maintains: Buy
Price Target: $390 → $90
Current: $14.20
Upside: +533.80%
Jun 21, 2023
Reiterates: Hold
Price Target: $25
Current: $11.71
Upside: +113.49%
Oct 2, 2020
Maintains: Hold
Price Target: $103 → $112
Current: $48.63
Upside: +130.31%